Clinical trial

Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer

NCT07489729

Study summary

ClinicalTrials.gov

Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

RADIATION · Unmapped registry intervention Hypofractionated Intensity-Modulated Radiation Therapy Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Conventional Intensity-Modulated Radiation Therapy Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-06-30

PhaseNA

Conditions

Hypofractionated Doseunresolved

Prostate Cancer Patientsunresolved

Interventions

Hypofractionated Intensity-Modulated Radiation TherapyRADIATION

Conventional Intensity-Modulated Radiation TherapyRADIATION

Sponsors & collaborators

Tanta Universitylead sponsor

Mapped research locations

TantaEgypt1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07489729 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.